Gold Miners Q1 Earnings Signal Sustained Momentum in Gold Bull Market AI Semiconductor Futures Set to Launch on CME Groups Compute Market US CLARITY Act Could Reshape Global Crypto Regulation Implications for Eastern Markets Chinas New Strategic Blueprint Signals Potential Shift in Global EV and AI Standards Ronald Reagan Institute Skepticism of Government Waste Claims Could Reshape Fiscal Debate Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions HHS Q2 2025 Earnings Narrower Loss and Modest Stock Gain Amid Sparse Disclosures BOH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment MPTI Q1 2026 Earnings EPS Surpasses Estimates by 1133 as Company Delivers Strong Profitability CMCT Q3 2024 Earnings Significant EPS Miss Highlights Challenges Yet Stock Advances PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Meridian Holdings Inc MRDN Gains 164 as Price Approaches Key Resistance OneSpan Inc OSPN Rallies 258 as Price Approaches Key Resistance ProCap Acquisition Corp Warrant PCAPW Holds Steady at 032 Traders Eye Key Levels Flux Power Holdings FLUX Surges 6 as Stock Approaches Key Resistance Visteon Corporation VC Shows Resilience with 111 Gain Key Levels to Watch US and Iran Show Signs of Progress in Talks but Disagreements Over Enriched Uranium and Strait of Hormuz Tolls Persist AMSF Q1 2026 Earnings EPS Misses Expectations as Margin Pressures Mount 1stdibscom Inc DIBS Tests Support Zone After Recent Uptick M3Brigade Acquisition V Corp Units MBAVU Edges Higher in Cautious Trading Title Civeo Corporation CVEO Edges Higher Testing Key Resistance Near 372 BlackRock TCP Capital Corp TCPC Climbs 176 as Price Approaches Key Resistance Elevance Health Inc ELV Gains 125 as Stock Holds Above Key Support CytomX Therapeutics CTMX Faces Selling Pressure as Stock Declines 26 Towards Key Support Protalix BioTherapeutics PLX Holds Steady Above Support Key Levels to Watch CNS Pharmaceuticals CNSP Surges Over 7 as Biotech Momentum Builds